 Shares of Teva Pharmaceutical Industries Ltd. TEVA, 5.81 hiked up 5.0 toward a six-week high in afternoon trading Friday, putting them on track for a ninth-straight gain, after Bernstein analyst Aaron Gal turned bullish on the long suffering generic drug maker. 